Back

Characterization of high-power and very-high-power short-duration radiofrequency lesions performed with a new-generation catheter and a temperature-control ablation mode

3 April 2022 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: ePosters Day 1 Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2022

About the speaker

Photo
Ms Cristina Lozano-Granero

Ramon y Cajal Hospital, Madrid (Spain)

128 More presentations in this session

Presentation thumbnail
Detection of endo-epicardial atrial low-voltage areas using unipolar and omnipolar voltage mapping
Mr M. Van Schie (Rotterdam, NL)
Abstract Slides
Presentation thumbnail
Atrial high-rate episodes in patients with devices without a history of atrial fibrillation
Doctor I. Doundoulakis (Brussels, BE)
Abstract Slides
Presentation thumbnail
The impact of different fat depots in the body on the progression of atrial fibrillation - data from RACE V
Doctor V. Weberndoerfer (Maastricht, NL)
Abstract Slides
Presentation thumbnail
Pulsed field ablation of atrial fibrillation: recurrence rate after first pulmonary vein isolation and first insights into durability at redo procedures
Mr T. Kueffer (Bern, CH)
Abstract Slides
Presentation thumbnail
Early mortality and complications following first-time catheter ablation of atrial fibrillation in a nationwide cohort
Doctor C. Witt (Aarhus, DK)
Abstract Slides

Access the full session

Session thumbnail
ePosters Day 1

The Event

Event poster

EHRA 2022

3 April - 5 April 2022
You may be interested in
thumbnail
Congress Presentation
Peri-procedural anesthesia and patient pain experience in pulmonary vein isolation by means of very high power short duration radiofrequency ablation.
thumbnail
Congress Presentation
A new criterium for optimal energy application in ultra-high-power short-duration ablation
thumbnail
Congress Presentation
Cavotricuspid isthmus ablation by means of very high power short duration temperature controlled lesions: acute and mid term outcome

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources